Article: Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19.
2021 Volume 13, Issue 1, Page(s) e13026
Abstract: ... anti-phospholipid antibodies in the context of COVID-19 could be one of the factors for elucidating ... pulmonary embolism and transient anti-phospholipid antibodies. At the time of presentation with acute ... We report two cases of coronavirus disease 2019 (COVID-19) in patients who developed ...
| Abstract | We report two cases of coronavirus disease 2019 (COVID-19) in patients who developed pulmonary embolism and transient anti-phospholipid antibodies. At the time of presentation with acute pulmonary embolism, both patients had leukocytosis and increased levels of anti-cardiolipin antibodies, which resolved at testing 12 weeks after initial presentation. Studying cases of pulmonary embolism and increased anti-phospholipid antibodies in the context of COVID-19 could be one of the factors for elucidating the possible connection between severe acute respiratory syndrome coronavirus 2 infection, anti-phospholipid antibodies, and thrombosis. |
|---|---|
| Language | English |
| Publishing date | 2021-01-31 |
| Publishing country | United States |
| Document type | Case Reports |
| ZDB-ID | 2747273-5 |
| ISSN | 2168-8184 |
| ISSN | 2168-8184 |
| DOI | 10.7759/cureus.13026 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.